This resolution designates the week of January 25-31, 2026, as "National School Choice Week" to recognize educational options for K-12 students. It encourages parents to learn about school choices and urges the public to host events raising awareness about diverse education environments, including public schools, charter schools, private schools, and homeschooling. The resolution has no policy or funding impact - it is a ceremonial designation acknowledging existing annual events celebrating educational choice.
The SAVE Moms and Babies Act of 2026 prohibits the FDA from approving new abortion drugs or granting investigational exemptions for them. It requires existing approved abortion drugs to be dispensed only in-person by certified healthcare providers in clinics or hospitals (not pharmacies), mandates providers to verify pregnancy duration and handle complications, and enforces strict adverse event reporting to the FDA. The bill directly affects healthcare providers prescribing abortion drugs, patients seeking these medications, and the FDA’s regulatory authority over such drugs. Key provisions include banning use after 70 days gestation, requiring provider certification for specific medical capabilities, and mandating documentation of risks to patients.
This bill requires states to annually submit to the federal government a list of private adoption agencies licensed by the state, in good standing, and tax-exempt under IRS Section 501(c)(3). The federal Children’s Bureau will compile and publish this information publicly. States that fail to submit the required list risk losing federal incentive payments for adoption and legal guardianship programs. The bill also mandates annual reports to Congress identifying any state-licensed agency not included on the national list and any disciplinary actions taken against such agencies.
This bill requires providers receiving federal funds to provide detailed, FDA-approved drug warnings about chemical abortions to patients at least 24 hours before the procedure. It mandates that providers highlight warnings and adverse reactions from the drug label, read them to patients, and obtain written confirmation. Non-compliant providers risk losing federal funding, and patients can sue for damages if providers fail to follow these requirements. The law specifically excludes medical emergencies like ectopic pregnancies or miscarriage treatment from its definition of "chemical abortion."
HR 7235, the "Protecting Motherhood Act," requires all federal agencies to stop using the term "birthing person" in official documents and instead use specific terms like "female," "mother," "pregnant woman," or "woman." It directly affects federal agencies that produce regulations, forms, or communications, mandating the use of these defined terms when referring to individuals based on biological sex. The bill provides detailed definitions for terms like "female" (based on biological sex at conception) and "pregnant woman" (an adult human female carrying a child). The law takes effect 30 days after enactment. This is a procedural change focused solely on terminology in government documents, with no direct impact on healthcare access or services.
The Gulf War Survivor Benefits Update Act of 2025 would extend the deadline for surviving spouses of Persian Gulf War veterans to apply for certain VA benefits. It changes the current cutoff date (January 1, 2001) to ten years and one day after the Persian Gulf War ended, as defined by presidential proclamation or law. This extension would allow more surviving spouses to qualify for benefits they previously missed due to the old deadline. The bill directly affects surviving spouses of veterans who served in the Persian Gulf War and were ineligible under the prior cutoff.
HRES 1018 is a resolution calling for the U.S. government and international partners to prioritize women's rights in Haiti's crisis response. It specifically demands ensuring at least 30% of Haiti's leadership positions (including security, humanitarian, and election roles) are held by women, funding services for gender-based violence survivors, and requiring gender-disaggregated data collection in all aid programs. The resolution also urges rebuilding U.S. Women, Peace, and Security programs and mandates that all policies address women's distinct needs in Haiti's transition. This resolution directly affects U.S. foreign policy implementation and Haiti's transitional government, emphasizing that women's inclusion is critical for stability.
This bill requires the Social Security Administration to maintain at least the 2025 level of field office personnel and prevent closures without strict review. It mandates 180 days' public notice, two local hearings, and input from Congress and local governments before closing or reducing services at any office, with a 30-day moratorium pending Inspector General approval. The law directly affects Social Security beneficiaries, particularly vulnerable groups like seniors, people with disabilities, and those with language barriers who rely on in-person services. It also requires a detailed report to Congress on past closures, GSA's role in relocation decisions, and a 10-year plan to maintain service levels.
HR 7212 establishes a federal regulatory framework under the Food, Drug, and Cosmetic Act for "cannabinoid hemp products," directly affecting their manufacturers, distributors, retailers, and consumers. It mandates FDA registration for facilities and product listing, along with adherence to new manufacturing, testing, and labeling requirements for oral, inhalable, and topical cannabinoid hemp products. Key provisions include setting cannabinoid content limits, prohibiting certain ingredients and marketing practices (like appealing to children), requiring child-resistant packaging, and establishing a minimum purchase age of 21. The bill grants the FDA authority to enforce these rules through mandatory recalls, refusal of non-compliant imports, and penalties for violations, including selling "prohibited cannabinoid products" or to underage individuals. Additionally, it creates an advisory committee to provide recommendations on cannabinoid content limits and other regulatory matters.
The Language Access for All Act of 2026 requires federal agencies to ensure meaningful access to government services for people with limited English proficiency (LEP). Agencies must translate vital documents into languages commonly spoken in the U.S. (based on Census data), provide multilingual digital tools, interpretation services, and use bilingual staff as an alternative to professional interpreters. Each agency must create a language access plan within one year, detailing how it will serve LEP populations - including during emergencies - and annually certify compliance with technical standards. Noncompliance is treated as discrimination under civil rights law, with enforcement by the Department of Justice.
HR 7199, the Gerald’s Law Act, expands burial benefits for veterans who die at home while receiving VA hospice care. It adds a new eligibility category allowing burial allowances for veterans who were in VA hospice care at home *only if* they previously received VA hospital or nursing home care. The bill amends existing law to include this scenario under the veterans' burial allowance program. This change directly affects veterans receiving VA hospice care at home after prior VA facility-based care, ensuring they qualify for burial benefits similar to those who die in VA facilities. The policy change takes effect as if included in the 2020 Veterans Health Care Act.
HRES 1013 proposes creating a Permanent Select Committee on Aging in the U.S. House of Representatives. This committee would study aging-related issues affecting older Americans - including income, health, housing, employment, and long-term care - without having the power to pass laws. It would also work to coordinate government and private programs supporting seniors and review recommendations from the President or White House Conference on Aging. The resolution, introduced by Rep. Magaziner and Rep. Salazar, is currently referred to the House Rules Committee.
